Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.

Ma'koseh, Mohammad; Amarin, Rula; Tamimi, Faris; Sharaf, Baha'; Abufara, Alaa; Shahin, Omar; Manassra, Mohammed K M; Halahleh, Khalid

Ma'koseh, Mohammad; Amarin, Rula; Tamimi, Faris; Sharaf, Baha'; Abufara, Alaa; Shahin, Omar; Manassra, Mohammed K M; Halahleh, Khalid.

Afiliação

Ma'koseh M; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
Amarin R; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
Tamimi F; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
Sharaf B; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
Abufara A; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
Shahin O; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
Manassra MKM; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.
Halahleh K; Department of Medical Oncology, King Hussein Cancer Center, Amman, Jordan.

Blood Res ; 56(4): 279-284, 2021 Dec 31.

Article em En | MEDLINE | ID: mdl-34880141

Palavras-chave

Burkitt lymphoma; CALGB 1002; International Prognostic Index

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google